Visby Medical™, a leading innovator in rapid PCR diagnostics, has secured an additional $3.9 million from the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to ...

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

The Global Antibiotic Research & Development Partnership (GARDP) and the Swiss-based global biopharmaceutical company Debiopharm have signed a memorandum of understanding to develop Debio 1453, a ...

Testing new antibiotics in India, South Africa or Brazil, where they are needed most, makes scientific sense. But it’ s not without challenges. That's why in India, drug makers like Wockhardt are ...

Across 5 research centers, investigators evaluated the impact of eculizumab on thymoma-associated myasthenia gravis, a severe ...

Reports $709 million in preliminary1 full-year 2024 U.S. net product revenues$611 million in SYFOVRE® U.S. net product revenues, including $167 ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

The Vivalytic test is a PCR rapid test that specifically detects the six most common causes of bacterial meningitis in under ...

Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report: London, UK Friday, January 10, 2025, 14:00 Hrs [IST] Clarivate Plc, a l ...

The cause of death of Jan Balugani, 33, a butcher from Correggio, has been confirmed as Meningococcus B meningitis, following ...